We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2809:TSEKewpie Corporation Analysis

Data as of 2026-05-23 - not real-time

¥4,158.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kewpie Corp (2809.T) is trading at ¥4,158, comfortably above its 20‑day (¥4,048.85) and 50‑day (¥4,103.28) moving averages but still below the 200‑day level (¥4,241.25), indicating a short‑term bounce within a longer‑term downtrend. The MACD line sits at +14.95 with a negative signal line, generating a bullish histogram (+23.02) that contrasts with the overall bearish trend direction flagged by the model. Relative strength is neutral at 56, while daily volume has slipped to 248,900 shares, well under the 10‑day average of 376,620, suggesting waning momentum. Volatility remains elevated at roughly 29% over the past month, and the beta of –0.06 points to minimal systematic risk. Support is anchored near ¥3,928 and resistance near ¥4,213, leaving roughly a 12.5% upside potential to the analyst median target of ¥4,750. Market sentiment is exuberant, with a Fear & Greed Index of 91.6 (Extreme Greed), which may be pricing in some optimism.
Fundamentally, Kewpie delivers ¥518 bn of revenue with a modest 3.9% growth rate and maintains a respectable gross margin of 29.7%. The company’s PE of 18.8 and PB of 1.77 place it near fair value, while a low payout ratio of 24% and a dividend yield of 1.59% underscore dividend sustainability, supported by ¥83 bn of cash against ¥27 bn of debt. Operating and profit margins are thin (6.3% and 4.4% respectively), and forward EPS is projected to decline, tempering growth expectations. Analyst consensus remains positive with a “Buy” rating from eight analysts and a median price target of ¥4,750, implying about a 12% upside. Given its defensive consumer‑staples positioning, low beta, and solid balance sheet, the stock leans toward a value‑blend profile. Overall, the combination of modest upside, sustainable dividend, and defensive fundamentals supports a cautious yet optimistic investment stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at ¥4,213
  • Decreasing volume indicating weakening momentum
  • Bullish MACD histogram despite overall bearish trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst median target of ¥4,750 (~12% upside)
  • Undervalued valuation metrics (PE ~18.8, PB ~1.77)
  • Strong cash position and low debt

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Defensive consumer staples sector
  • Sustainable dividend with low payout ratio
  • Stable earnings and modest revenue growth

Key Metrics & Analysis

Financial Health

Revenue Growth3.90%
Profit Margin4.46%
P/E Ratio18.8
ROE7.76%
ROA4.83%
Debt/Equity7.73
P/B Ratio1.8

Technical Analysis

TrendBearish
RSI56.2
Support¥3,928.00
Resistance¥4,213.00
MA 20¥4,048.85
MA 50¥4,103.28
MA 200¥4,241.25
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Target Price¥4,681.25
Upside/Downside12.58%
GradeUndervalued
TypeBlend
Dividend Yield1.59%

Risk Assessment

Beta-0.06
Volatility29.38%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.